Terms: = Liver cancer AND HLF, Q16534, 3131, ENSG00000108924 AND Treatment
49 results:
1. Iron-saturated bovine lactoferrin: a promising chemopreventive agent for hepatocellular carcinoma.
Hernández-Galdámez HV; Fattel-Fazenda S; Flores-Téllez TNJ; Aguilar-Chaparro MA; Mendoza-García J; Díaz-Fernández LC; Romo-Medina E; Sánchez-Pérez Y; Arellanes-Robledo J; De la Garza M; Villa-Treviño S; Piña-Vázquez C
Food Funct; 2024 Apr; 15(8):4586-4602. PubMed ID: 38590223
[TBL] [Abstract] [Full Text] [Related]
2. Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines.
Takuma K; Fujihara S; Fujita K; Iwama H; Nakahara M; Oura K; Tadokoro T; Mimura S; Tani J; Shi T; Morishita A; Kobara H; Himoto T; Masaki T
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163589
[TBL] [Abstract] [Full Text] [Related]
3. Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
Cho Y; Lee S; Park SJ
PLoS One; 2021; 16(1):e0245911. PubMed ID: 33513172
[TBL] [Abstract] [Full Text] [Related]
4. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study.
Ma D; Wang J; Liu L; Chen M; Wang Z
BMC Cancer; 2020 Sep; 20(1):936. PubMed ID: 32993568
[TBL] [Abstract] [Full Text] [Related]
5. The Effect of Methylselenocysteine and Sodium Selenite treatment on microRNA Expression in liver cancer Cell Lines.
Lendvai G; Szekerczés T; Kontsek E; Selvam A; Szakos A; Schaff Z; Björnstedt M; Kiss A
Pathol Oncol Res; 2020 Oct; 26(4):2669-2681. PubMed ID: 32656599
[TBL] [Abstract] [Full Text] [Related]
6. Effects of Pyrrole-Imidazole Polyamides Targeting Human TGF-β1 on the Malignant Phenotypes of liver cancer Cells.
Takagi K; Midorikawa Y; Takayama T; Abe H; Fujiwara K; Soma M; Nagase H; Miki T; Fukuda N
Molecules; 2020 Jun; 25(12):. PubMed ID: 32585841
[TBL] [Abstract] [Full Text] [Related]
7. Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling.
Harada K; Ohashi R; Naito K; Kanki K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354204
[TBL] [Abstract] [Full Text] [Related]
8. Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells.
Cabral-Romero C; Solís-Soto JM; Sánchez-Pérez Y; Pineda-Aguilar N; Meester I; Pérez-Carrillo E; Nakagoshi-Cepeda SE; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Hernandez-Delgadillo R; Chellam S; García-Cuéllar CM
Anticancer Drugs; 2020 Mar; 31(3):251-259. PubMed ID: 31764012
[TBL] [Abstract] [Full Text] [Related]
9. Carboxypeptidase A6 Promotes the Proliferation and Migration of Hepatocellular Carcinoma by Up-regulating AKT Signaling Pathway.
Huang QB; Zhang HW; Liao ZB
Curr Med Sci; 2019 Oct; 39(5):727-733. PubMed ID: 31612389
[TBL] [Abstract] [Full Text] [Related]
10. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
[TBL] [Abstract] [Full Text] [Related]
11. Oncofetal hlf transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance.
Xiang DM; Sun W; Zhou T; Zhang C; Cheng Z; Li SC; Jiang W; Wang R; Fu G; Cui X; Hou G; Jin GZ; Li H; Hou C; Liu H; Wang H; Ding J
Gut; 2019 Oct; 68(10):1858-1871. PubMed ID: 31118247
[TBL] [Abstract] [Full Text] [Related]
12. [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells].
Dai J; Niu K; Wang B; Li Y; Xia C; Tao K; Dai J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 May; 34(5):427-433. PubMed ID: 30043734
[TBL] [Abstract] [Full Text] [Related]
13. Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression.
Rani B; Malfettone A; Dituri F; Soukupova J; Lupo L; Mancarella S; Fabregat I; Giannelli G
Cell Death Dis; 2018 Mar; 9(3):373. PubMed ID: 29515105
[TBL] [Abstract] [Full Text] [Related]
14. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
[TBL] [Abstract] [Full Text] [Related]
15. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress liver cancer Stem Cells.
Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
[TBL] [Abstract] [Full Text] [Related]
16. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
[TBL] [Abstract] [Full Text] [Related]
17. Potent anticancer activity of a new bismuth (III) complex against human lung cancer cells.
Ouyang R; Yang Y; Tong X; Feng K; Yang Y; Tao H; Zhang X; Zong T; Cao P; Xiong F; Guo N; Li Y; Miao Y; Zhou S
J Inorg Biochem; 2017 Mar; 168():18-26. PubMed ID: 28006662
[TBL] [Abstract] [Full Text] [Related]
18. Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.
Higashi T; Hayashi H; Kitano Y; Yamamura K; Kaida T; Arima K; Taki K; Nakagawa S; Okabe H; Nitta H; Imai K; Hashimoto D; Chikamoto A; Beppu T; Baba H
Med Oncol; 2016 Nov; 33(11):123. PubMed ID: 27734263
[TBL] [Abstract] [Full Text] [Related]
19. treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T
Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201
[TBL] [Abstract] [Full Text] [Related]
20. Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
Sugai S; Yoshikawa T; Iwama T; Tsuchiya N; Ueda N; Fujinami N; Shimomura M; Zhang R; Kaneko S; Uemura Y; Nakatsura T
Int J Oncol; 2016 May; 48(5):1794-804. PubMed ID: 26936487
[TBL] [Abstract] [Full Text] [Related]
[Next]
